T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine

05-2025

POSTER: Enhancing Immunogenicity Risk Assessment: Leveraging ISPRI for Bispecific Antibody Analysis

04-2025

Regulatory T cell epitope content in human antibodies decreases during maturation

04-2025

Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches

03-2025

Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods

08-2024

Poster: Immunogenicity Risk Assessment of Salmon Calcitonin Peptide Impurities Using In Silico and In Vitro Methods

05-2024

Poster: Rapid and Predictive Immunogenicity Risk Assessments Using In Silico Methods

05-2024

Poster: Comprehensive assessment of immunogenicity risk of host cell proteins in biologics and vaccines using in silico and in vitro methods

05-2024

Poster: An “I” (Immunogenicity Risk Assessment) for an Eye (Ophthalmology Biologics)

05-2024

Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis

05-2024

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

04-2024

Neoadjuvant personalized cancer vaccines: the final frontier?

01-2024